Cite
P1459: SAFETY AND EFFICACY FINDINGS OF AUTO1, A FAST‐OFF RATE CD19 CAR, IN RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN'S LYMPHOMA (B‐NHL), AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) / SMALL LYMPHOCYTIC LYMPHOMA (SLL)
MLA
Roddie, C., et al. “P1459: Safety and Efficacy Findings of Auto1, a Fast‐Off Rate Cd19 Car, in Relapsed/Refractory B‐Cell Non‐Hodgkin’s Lymphoma (B‐Nhl), and Chronic Lymphocytic Leukemia (Cll) / Small Lymphocytic Lymphoma (Sll).” HemaSphere, vol. 6, June 2022, pp. 1341–42. EBSCOhost, https://doi.org/10.1097/01.HS9.0000848692.42285.0c.
APA
Roddie, C., Dias, J., O’Reilly, M., Mitsikakou, M., Charalambous, E., Green, L., Vaughan, M., Agliardi, G., Garcia, J., Lewin, E., Lowdell, M., Marzolini, M., Wood, L., Holmes, H., Ngai, Y., Popova, B., Wilson, W., Kunaseelan, S., Spanswick, V., & Lowe, H. (2022). P1459: Safety and Efficacy Findings of Auto1, a Fast‐Off Rate Cd19 Car, in Relapsed/Refractory B‐Cell Non‐Hodgkin’s Lymphoma (B‐Nhl), and Chronic Lymphocytic Leukemia (Cll) / Small Lymphocytic Lymphoma (Sll). HemaSphere, 6, 1341–1342. https://doi.org/10.1097/01.HS9.0000848692.42285.0c
Chicago
Roddie, C., J. Dias, M. O’Reilly, M. Mitsikakou, E. Charalambous, L. Green, M. Vaughan, et al. 2022. “P1459: Safety and Efficacy Findings of Auto1, a Fast‐Off Rate Cd19 Car, in Relapsed/Refractory B‐Cell Non‐Hodgkin’s Lymphoma (B‐Nhl), and Chronic Lymphocytic Leukemia (Cll) / Small Lymphocytic Lymphoma (Sll).” HemaSphere 6 (June): 1341–42. doi:10.1097/01.HS9.0000848692.42285.0c.